{
  "id": 14131,
  "label": "glioma susceptibility 3",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0013093",
  "properties": {
    "xrefs": [
      "GARD:0027837",
      "MEDGEN:442777",
      "OMIM:613029",
      "UMLS:C2751641"
    ],
    "synonyms": [
      "BRCA2 malignant glioma",
      "glioblastoma 3",
      "glioma susceptibility 3",
      "glioma susceptibility type 3",
      "malignant glioma caused by mutation in BRCA2",
      "GLM3"
    ],
    "categories": [
      {
        "ref": "MONDO:0002254",
        "name": "syndromic disease"
      }
    ],
    "definition": "Any malignant glioma in which the cause of the disease is a mutation in the BRCA2 gene."
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 23982,
      "label": "glioma susceptibility",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        16218
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "GARD:0027996",
          "OMIMPS:137800"
        ],
        "synonyms": [
          "glioma, susceptibility",
          "glioma, susceptibility to"
        ],
        "categories": [
          {
            "ref": "MONDO:0002254",
            "name": "syndromic disease"
          }
        ],
        "definition": "An inherited susceptibility or predisposition to developing glioma."
      },
      "child_count": 10,
      "reference_id": "MONDO:0100242"
    },
    {
      "id": 24664,
      "label": "BRCA2-related cancer predisposition",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        16218
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "GARD:0026409"
        ],
        "categories": [
          {
            "ref": "MONDO:0002254",
            "name": "syndromic disease"
          }
        ],
        "definition": "Hereditary cancer predisposition due to variation(s) in the BRCA2 gene. Germline pathogenic or likely pathogenic variants in the BRCA2 gene confer an autosomal dominant predisposition to hereditary breast and ovarian cancer. Tumor formation at other sites, including pancreatic and prostate cancer, have been described."
      },
      "child_count": 3,
      "reference_id": "MONDO:0700269"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 23982,
      "label": "glioma susceptibility"
    },
    {
      "id": 24664,
      "label": "BRCA2-related cancer predisposition"
    }
  ]
}